John P. McGrath

7.6k citations

41 papers · 6.3k indexed · 5 hit papers · h-index 22

Impact in

Oncology top 1%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
Molecular Biology top 1%
- Ubiquitin and proteasome pathways
- Fungal and yeast genetics research
- Glycosylation and Glycoproteins Research
- Protein Kinase Regulation and GTPase Signaling

Papers in

Molecular Biology 30
- Ubiquitin and proteasome pathways 7
- Epigenetics and DNA Methylation 5
- Fungal and yeast genetics research 5
- RNA Interference and Gene Delivery 4
- Biochemical and Molecular Research 3
- Histone Deacetylase Inhibitors Research 3
Genetics 10
- Virus-based gene therapy research 8

Co-authors: Alexander Varshavsky Arthur D. Levinson Stefan Jentsch David V. Goeddel Daniel J. Capon Peter H. Seeburg Joseph Schlessinger Alane Gray
Journals: Nature (6 papers)Molecular and Cellular Biology (4 papers)Cell (2 papers)The EMBO Journal (2 papers)Science (2 papers)
Partner nations: United States Germany Slovakia

In The Last Decade

John P. McGrath

38 papers receiving 5.9k citations

Hit Papers

5 papers align trajectories log scale

The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein 1989 · 511 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

1989 Nature
1987 Nature
1985 Science
1984 Nature
1983 Nature

Peers

Countries citing papers authored by John P. McGrath

Since Specialization

Citations

This map shows the geographic impact of John P. McGrath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. McGrath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. McGrath more than expected).

Fields of papers citing papers by John P. McGrath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. McGrath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. McGrath. The network helps show where John P. McGrath may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John P. McGrath, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John P. McGrath Line = papers co-authored together John P. McGrath links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Merkel cell polyomavirus activates LSD1-mediated blockade of non-canonical BAF to regulate transformation and tumorigenesis Nature Cell Biology ·Donglim Esther Park, Jingwei Cheng, John P. McGrath, Stephanie Brown Snell, 昌孝関口, Selene K. Swanson, Michelle Tillgren, João A. Paulo, Prafulla C. Gokhale, Laurence Florens, Michael P. Washburn, Patrick Trojer, James A. DeCaprio	2020	49
2	Design and Synthesis of Styrenylcyclopropylamine LSD1 Inhibitors ACS Medicinal Chemistry Letters ·Victor Gehling, John P. McGrath, Martin Duplessis, Isabela Neis, Don Ebert, Rishi G. Vaswani, Alexandre Côté, Jacob I. Stuckey, Jesús Yair Rojas Reyes, Richard Cummings, Srividya Balasubramanian, Priyadarshini Iyer, Kaitlin McGarragle, Andrew C. Good, Brian K. Albrecht, Jean-Christophe Harmange, James E. Audia, Steven F. Bellon, Patrick Trojer, Julian Levell	2020	18
3	Pharmacological Inhibition of the Histone Lysine Demethylase KDM1A Suppresses the Growth of Multiple Acute Myeloid Leukemia Subtypes Cancer Research ·John P. McGrath, Kaylyn E. Williamson, Srividya Balasubramanian, Shobu Odate, Shilpi Arora, Charlie Hatton, Thomas M. Edwards, Thomas O’Brien, Steven Magnuson, David Stokoe, Danette L. Daniels, Barbara M. Bryant, Patrick Trojer	2016	70
4	Targeting histone lysine methylation in cancer Pharmacology & Therapeutics ·John P. McGrath, Patrick Trojer	2015	150
5	Cellular Toxicity Induced by SRF-Mediated Transcriptional Squelching Toxicological Sciences ·Haifan Lin, John P. McGrath, Pengliang Wang, Sajad Ahmad Lone	2006	19
6	Evaluation of the Erythroid Regenerative Response in Two Different Models of Experimentally Induced Iron Deficiency Anemia Veterinary Clinical Pathology ·Mary Jo Burkhard, Diane E. Brown, John P. McGrath, F. Campanello, В.В. Чебыкин, Masaya Kato, Wherly P. Hoffman, Л А Сторожук, Gabriel dos S. Scatena, 林靖堯	2001	19
7	Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses Human Gene Therapy ·K. Reed Clark, Xiaoming Liu, John P. McGrath, Philip R. Johnson	1999	265
8	Production and Characterization of Fusion Proteins Containing Transferrin and Nerve Growth Factor Journal of drug targeting ·Zachary L. Kodesh, Ruth M. Starzyk, John P. McGrath, M Priyadharshini, Jonathan S. George, Minami TAYA, Mazzarri de Lauschner M, Scott D. Putney	1998	11
9	Bifunctional fusion between nerve growth factor and a transferrin receptor antibody Journal of Neuroscience Research ·John P. McGrath, Xueying Cao, Y. Cenatiempo, Mazzarri de Lauschner M, Ted Ebendal, M J Coloma, Sherie L. Morrison, Scott D. Putney	1997	17
10	An Essential Yeast Gene Encoding a Homolog of Ubiquitin-activating Enzyme Journal of Biological Chemistry ·R. Jürgen Dohmen, H. Oeschler, John P. McGrath, 孙良东, Jordan Kolarov, André Goffeau, Alexander Varshavsky	1995	171
11	Vancomycin-induced release of histamine from rat peritoneal mast cells and a rat basophil cell line (RBL-1) Inflammation Research ·Patricia D. Williams, Dennis A. Laska, Sweetwater Reporter, John P. McGrath, Sandy White, D. M. Hoover	1991	14
12	Evaluation of flow cytometric counting procedure for canine reticulocytes by use of thiazole orange American Journal of Veterinary Research ·Gabriel dos S. Scatena, John P. McGrath	1991	10
13	Cure of Experimental Human Malignant Mesothelioma in Athymic Mice by Diphtheria Toxin JNCI Journal of the National Cancer Institute ·Vic Raso, John P. McGrath	1989	11
14	The yeast STE6 gene encodes a homologue of the mammalian multidrug resistance P-glycoprotein Nature ·John P. McGrath, Alexander Varshavsky Hit paper breakdown →	1989	511
15	Expression of normal and activated human Ha-ras cDNAs in Saccharomyces cerevisiae. Molecular and Cellular Biology ·A. Waal de, John P. McGrath, Arthur D. Levinson	1985	31
16	A Mutation at the ATP-Binding Site of pp60^v-src Abolishes Kinase Activity, Transformation, and Tumorigenicity Molecular and Cellular Biology ·Mark A. Snyder, J. Michael Bishop, John P. McGrath, Arthur D. Levinson	1985	39
17	A mutation at the ATP-binding site of pp60v-src abolishes kinase activity, transformation, and tumorigenicity. Molecular and Cellular Biology ·Mark A. Snyder, J. Michael Bishop, John P. McGrath, Arthur D. Levinson	1985	109
18	Structure and organization of the human Ki-ras proto-oncogene and a related processed pseudogene Nature ·John P. McGrath, Daniel J. Capon, Douglas H. Smith, Ellson Y. Chen, Peter H. Seeburg, David V. Goeddel, Arthur D. Levinson	1983	305
19	Activation of Ki-ras2 gene in human colon and lung carcinomas by two different point mutations Nature ·Daniel J. Capon, Peter H. Seeburg, John P. McGrath, Joel S. Hayflick, Ursula Edman, Arthur D. Levinson, David V. Goeddel Hit paper breakdown →	1983	473
20	The product of the retroviral transforming gene v-myb is a truncated version of the protein encoded by the cellular oncogene c-myb Cell ·Karl-Heinz Klempnauer, Gary Ramsay, J. Michael Bishop, Berenilde Valéria de Oliveira Souza, C. Moscovici, John P. McGrath, Arthur D. Levinson	1983	177

About John P. McGrath

John P. McGrath is a scholar working on Molecular Biology, Genetics, Oncology, Hematology and Cellular and Molecular Neuroscience, having authored 41 papers that have together received 6.3k indexed citations. Recurring topics across this work include Virus-based gene therapy research (8 papers), Ubiquitin and proteasome pathways (7 papers), Epigenetics and DNA Methylation (5 papers), Fungal and yeast genetics research (5 papers), RNA Interference and Gene Delivery (4 papers), Nerve injury and regeneration (4 papers), Biochemical and Molecular Research (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). The work is most often cited by research in Oncology (2.3k citations), Molecular Biology (4.5k citations), Radiology, Nuclear Medicine and Imaging (1.0k citations), Cell Biology (681 citations) and Genetics (907 citations). John P. McGrath has collaborated with scholars based in United States, Germany and Slovakia. Frequent co-authors include Alexander Varshavsky, Arthur D. Levinson, Stefan Jentsch, David V. Goeddel, Daniel J. Capon, Peter H. Seeburg, Joseph Schlessinger, Alane Gray, Lisa M. Coussens and Axel Ullrich. Their work appears in journals such as Nature, Molecular and Cellular Biology, Cell, The EMBO Journal and Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact